Correlation
The correlation between GILD and MRK is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
GILD vs. MRK
Compare and contrast key facts about Gilead Sciences, Inc. (GILD) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GILD or MRK.
Performance
GILD vs. MRK - Performance Comparison
Loading data...
Key characteristics
GILD:
2.89
MRK:
-1.32
GILD:
3.88
MRK:
-1.85
GILD:
1.49
MRK:
0.75
GILD:
2.65
MRK:
-0.86
GILD:
14.34
MRK:
-1.51
GILD:
5.48%
MRK:
24.63%
GILD:
27.30%
MRK:
27.72%
GILD:
-70.82%
MRK:
-68.63%
GILD:
-5.59%
MRK:
-40.85%
Fundamentals
GILD:
$136.93B
MRK:
$192.95B
GILD:
$4.76
MRK:
$6.88
GILD:
23.13
MRK:
11.17
GILD:
0.23
MRK:
0.70
GILD:
4.77
MRK:
3.02
GILD:
7.15
MRK:
3.99
GILD:
$28.73B
MRK:
$63.92B
GILD:
$22.50B
MRK:
$51.75B
GILD:
$10.58B
MRK:
$27.30B
Returns By Period
In the year-to-date period, GILD achieves a 20.01% return, which is significantly higher than MRK's -22.09% return. Over the past 10 years, GILD has underperformed MRK with an annualized return of 3.14%, while MRK has yielded a comparatively higher 6.14% annualized return.
GILD
20.01%
6.17%
20.74%
77.71%
24.03%
11.60%
3.14%
MRK
-22.09%
-7.62%
-23.14%
-36.98%
-3.10%
3.07%
6.14%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GILD vs. MRK — Risk-Adjusted Performance Rank
GILD
MRK
GILD vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GILD vs. MRK - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 2.82%, less than MRK's 4.11% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 2.82% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% |
MRK Merck & Co., Inc. | 4.11% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.42% | 3.11% |
Drawdowns
GILD vs. MRK - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.82%, roughly equal to the maximum MRK drawdown of -68.63%. Use the drawdown chart below to compare losses from any high point for GILD and MRK.
Loading data...
Volatility
GILD vs. MRK - Volatility Comparison
Gilead Sciences, Inc. (GILD) has a higher volatility of 12.15% compared to Merck & Co., Inc. (MRK) at 11.25%. This indicates that GILD's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
GILD vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GILD vs. MRK - Profitability Comparison
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Gilead Sciences, Inc. reported a gross profit of 5.13B and revenue of 6.67B. Therefore, the gross margin over that period was 76.9%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Gilead Sciences, Inc. reported an operating income of 2.24B and revenue of 6.67B, resulting in an operating margin of 33.6%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Gilead Sciences, Inc. reported a net income of 1.32B and revenue of 6.67B, resulting in a net margin of 19.7%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.